Use of Nebulized Tranexamic Acid (TA) in Combination With Nebulized Recombinant Coagulation Factor VIIa to Treat Hemoptysis in Pediatric Patients With Cancer At End-Of-Life (EOL)

已完结 10 由蓝发布于 2026/5/10 17:48:27

DOI: 10.1016/j.jpainsymman.2025.11.005
文献类型：期刊论文
补充材料：只需要正文
文献链接：https://doi.org/10.1016/j.jpainsymman.2025.11.005

Elsevier

Abstract：Hemoptysis is a distressing symptom for both patients and families at end of life (EOL). In the acute care setting, this can be managed surgically or medically. However, research regarding i

应助信息

1天前

蟹黄

202605110906106937114.pdf 已采纳

2026-05-10

Book学术机器人

2026/5/10 17:48:27 未找到该文献，机器人已退出，请等待人工下载

2026/5/10 17:48:27 Book学术AI机器人收到请求，开始寻找文献

2026/5/10 17:48:27 已向机器人发送请求

2026-05-10

蓝发布求助

上一个求助:其它数据库Naturally Fractured Carbonate Reservoir Characterization: A Case Study of a Mature High-Pour Point Oil Field in Hungary 下一个求助:American Chemical Society (ACS)Roll-to-Roll Scalable Manufacturing of Nanoporous Separators for High-Safety Lithium-Ion Batteries